Ishikawa, Tomofumi
Sakai, Takamasa
Iwama, Noriyuki
Obara, Ryo
Morishita, Kei
Adomi, Motohiko
Kunitoki, Tadaharu
Noda, Aoi
Ishikuro, Mami
Kikuchi, Saya
Kobayashi, Natsuko
Tomita, Hiroaki
Saito, Masatoshi
Nishigori, Hidekazu
Kuriyama, Shinichi
Mano, Nariyasu
Obara, Taku
Funding for this research was provided by:
Japan Society for the Promotion of Science (25K13625)
Ministry of Health, Labour and Welfare (H23-iyaku-ippan-006)
Article History
Received: 18 February 2026
Accepted: 8 May 2026
First Online: 23 May 2026
Declarations
:
: Tomofumi Ishikawa is an employee of Pfizer R&D Japan and a research collaborator at Tohoku University and has contributed to the present study independently of Pfizer R&D Japan. Nariyasu Mano received presentation fees from Daiichi Sankyo Co. Ltd. The authors declare no conflicts of interest. The dataset used was managed, and the analysis was confirmed by the corresponding author.
: Not applicable.